Voglistar R1 Tablet - Strip of 10

Voglistar R1 Tablet is a pharmaceutical product specifically designed for the management of type 2 diabetes mellitus. This medication is a combination of two active ingredients: Repaglinide and Voglibose. Repaglinide is an oral hypoglycemic agent that stimulates the pancreas to release insulin, particularly after meals, thereby helping to lower blood sugar levels. On the other hand, Voglibose is an alpha-glucosidase inhibitor that works by slowing down the digestion and absorption of carbohydrates in the intestines, which helps prevent rapid spikes in blood glucose levels following meals. The primary therapeutic purpose of Voglistar R1 Tablet is to control high blood sugar levels in individuals who have not achieved adequate glycemic control with diet and exercise alone or with other antidiabetic medications. It is crucial for patients to adhere to their prescribed treatment regimen, including maintaining a balanced diet and engaging in regular physical activity, to optimize the effectiveness of Voglistar R1 Tablet. This medication should be taken just after meals to align with its mechanism of action, ensuring that it effectively manages postprandial blood glucose levels. Patients are advised not to discontinue use without consulting their healthcare provider, as abrupt cessation may lead to increased blood sugar levels and potential complications such as kidney damage or vision problems. Regular monitoring of blood glucose levels is essential while using Voglistar R1 Tablet to ensure that the medication is working effectively and to make any necessary adjustments in therapy. Overall, Voglistar R1 Tablet plays a vital role in the comprehensive management of type 2 diabetes, contributing to improved health outcomes and quality of life for patients.